Literature DB >> 9921871

Multiple sclerosis associated with uveitis in two large clinic-based series.

V Biousse1, C Trichet, E Bloch-Michel, E Roullet.   

Abstract

The authors reviewed records from consecutive patients in an MS clinic (n = 1,098) and in a uveitis clinic (n = 1,530) to select patients with "definite MS" and uveitis. A total of 28 of 2,628 patients (1%) were identified: 12 from the MS clinic (12 of 1,098; 1.1%) and 16 from the uveitis clinic (16 of 1,530; 1%). Pars planitis and panuveitis were most commonly encountered. The delay between the onset of neurologic and ocular symptoms (mean, 9 years) emphasizes the importance of a sequential diagnostic search throughout the patient's course.

Entities:  

Mesh:

Year:  1999        PMID: 9921871     DOI: 10.1212/wnl.52.1.179

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

1.  [Manifestation of multiple sclerosis under treatment with infliximab for intermediate uveitis].

Authors:  M Sczesny-Kaiser; M Veit; C Heinz; A Heiligenhaus; M Tegenthoff; P Schwenkreis
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

2.  Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies.

Authors:  Farzin Forooghian; Melanie Sproule; Carol Westall; Lynn Gordon; Guy Jirawuthiworavong; Kaori Shimazaki; Paul O'Connor
Journal:  Doc Ophthalmol       Date:  2006-09-14       Impact factor: 2.379

3.  The approach to bilateral simultaneous isolated optic neuritis.

Authors:  L Frohman
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

4.  Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases.

Authors:  Ruth Ann Marrie; Ralph I Horwitz; Gary Cutter; Tuula Tyry; Timothy Vollmer
Journal:  Neuroepidemiology       Date:  2011-02-01       Impact factor: 3.282

5.  Multiple Sclerosis and Panuveitis: A Rare Association.

Authors:  Burcu Gökçe Çokal; H Nalan Güneş; Selda Keskin Güler; Tahir Kurtuluş Yoldaş; Caner Baydar; Sevim Kavuncu
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

Review 6.  The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis.

Authors:  Gregory Heath; Archana Airody; Richard Peter Gale
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

Review 7.  Gender disparities in ocular inflammatory disorders.

Authors:  Hatice Nida Sen; Janet Davis; Didar Ucar; Austin Fox; Chi Chao Chan; Debra A Goldstein
Journal:  Curr Eye Res       Date:  2014-07-02       Impact factor: 2.424

8.  Characteristics of morphologic macular abnormalities in neuroimmunology practice.

Authors:  Omar Al-Louzi; Elias S Sotirchos; Angela Vidal-Jordana; Shin C Beh; Julia Button; Howard S Ying; Laura J Balcer; Elliot M Frohman; Shiv Saidha; Peter A Calabresi; Scott D Newsome
Journal:  Mult Scler       Date:  2017-11-10       Impact factor: 6.312

Review 9.  [Uveitis in multiple sclerosis : Overview and perspectives].

Authors:  A L Hildebrandt; F Mackensen
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

10.  Interferons and their potential in the treatment of ocular inflammation.

Authors:  Friederike Mackensen; Regina Max; Matthias D Becker
Journal:  Clin Ophthalmol       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.